Jänne PA - Search Results

1

Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.

Lynch TJ, Adjei AA, Bunn PA Jr, Eisen TG, Engelman J, Goss GD, Haber DA, Heymach JV, Jänne PA, Johnson BE, Johnson DH, Lilenbaum RC, Meyerson M, Sandler AB, Sequist LV, Settleman J, Wong KK, Hart CS. Lynch TJ, et al. Among authors: janne pa. Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4365s-4371s. doi: 10.1158/1078-0432.CCR-06-1005. Clin Cancer Res. 2006. PMID: 16857812 No abstract available.

2

Lung cancer presenting with solitary bone metastases. Case 2: acrometastasis as an initial presentation of non-small-cell lung carcinoma.

Jänne PA, Datta MW, Johnson BE. Jänne PA, et al. J Clin Oncol. 1999 Sep;17(9):2998-3001. doi: 10.1200/JCO.1999.17.9.2998. J Clin Oncol. 1999. PMID: 10561378 No abstract available.

3

Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment during pregnancy.

Jänne PA, Rodriguez-Thompson D, Metcalf DR, Swanson SJ, Greisman HA, Wilkins-Haug L, Johnson BE. Jänne PA, et al. Oncology. 2001;61(3):175-83. doi: 10.1159/000055371. Oncology. 2001. PMID: 11574771 Review.

4

Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.

Jänne PA, Taffaro ML, Salgia R, Johnson BE. Jänne PA, et al. Cancer Res. 2002 Sep 15;62(18):5242-7. Cancer Res. 2002. PMID: 12234991

5

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.

Jänne PA, Freidlin B, Saxman S, Johnson DH, Livingston RB, Shepherd FA, Johnson BE. Jänne PA, et al. Cancer. 2002 Oct 1;95(7):1528-38. doi: 10.1002/cncr.10841. Cancer. 2002. PMID: 12237922 Free article.

6

Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study.

Wirth LJ, Lucca J, Ostler P, Fidias P, Lynch C, Jänne PA, Herbst RS, Johnson BE, Sugarbaker DJ, Mathisen DJ, Lukanich JM, Choi NC, Berman SM, Skarin AT. Wirth LJ, et al. Among authors: janne pa. Clin Cancer Res. 2003 May;9(5):1698-704. Clin Cancer Res. 2003. PMID: 12738723 Clinical Trial.

7

The role of epidermal growth factor receptor in advanced non-small cell lung carcinoma.

Jänne PA. Jänne PA. Ann Med. 2003;35(7):450-7. doi: 10.1080/07853890310010889. Ann Med. 2003. PMID: 14649327 Review.

8

Prospective study of the airways and pulmonary parenchyma of patients at risk for a second lung cancer.

Means-Markwell M, Linnoila RI, Williams J, Jänne PA, Kaye F, O'Neil K, Johnson BE. Means-Markwell M, et al. Among authors: janne pa. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5915-21. Clin Cancer Res. 2003. PMID: 14676115

9

High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines.

Jänne PA, Li C, Zhao X, Girard L, Chen TH, Minna J, Christiani DC, Johnson BE, Meyerson M. Jänne PA, et al. Oncogene. 2004 Apr 8;23(15):2716-26. doi: 10.1038/sj.onc.1207329. Oncogene. 2004. PMID: 15048096

10

Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy.

Wirth LJ, Carter MR, Jänne PA, Johnson BE. Wirth LJ, et al. Among authors: janne pa. Lung Cancer. 2004 May;44(2):213-20. doi: 10.1016/j.lungcan.2003.11.016. Lung Cancer. 2004. PMID: 15084386

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

474 results

Search Page